ATE326219T1 - Verwendung von aryl-cyclohexylamine derivaten zur herstellung von nmda-rezeptorblockern - Google Patents
Verwendung von aryl-cyclohexylamine derivaten zur herstellung von nmda-rezeptorblockernInfo
- Publication number
- ATE326219T1 ATE326219T1 AT99115114T AT99115114T ATE326219T1 AT E326219 T1 ATE326219 T1 AT E326219T1 AT 99115114 T AT99115114 T AT 99115114T AT 99115114 T AT99115114 T AT 99115114T AT E326219 T1 ATE326219 T1 AT E326219T1
- Authority
- AT
- Austria
- Prior art keywords
- aryl
- producing
- nmda receptor
- receptor blockers
- cyclohexylamine derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98115484 | 1998-08-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE326219T1 true ATE326219T1 (de) | 2006-06-15 |
Family
ID=8232474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99115114T ATE326219T1 (de) | 1998-08-18 | 1999-08-09 | Verwendung von aryl-cyclohexylamine derivaten zur herstellung von nmda-rezeptorblockern |
Country Status (24)
Country | Link |
---|---|
US (1) | US6184236B1 (de) |
JP (1) | JP3455142B2 (de) |
KR (1) | KR100341194B1 (de) |
CN (1) | CN1141936C (de) |
AR (1) | AR021770A1 (de) |
AT (1) | ATE326219T1 (de) |
AU (1) | AU756408B2 (de) |
BR (1) | BR9903779A (de) |
CA (1) | CA2280455A1 (de) |
DE (1) | DE69931316D1 (de) |
HR (1) | HRP990256A2 (de) |
HU (1) | HUP9902737A3 (de) |
ID (1) | ID23107A (de) |
IL (1) | IL131399A0 (de) |
MA (1) | MA26677A1 (de) |
MY (1) | MY133133A (de) |
NO (1) | NO993948L (de) |
NZ (1) | NZ337243A (de) |
PE (1) | PE20000955A1 (de) |
PL (1) | PL334949A1 (de) |
SG (1) | SG82014A1 (de) |
TR (1) | TR199902015A2 (de) |
YU (1) | YU38699A (de) |
ZA (1) | ZA995212B (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1292581B1 (de) * | 2000-06-06 | 2005-08-10 | Warner-Lambert Company LLC | Bicyclische cyclohexylamine und ihre verwendung als nmda-rezeptor antagonisten |
EP1436258A4 (de) * | 2001-03-08 | 2005-03-23 | Univ Emory | Ph-wert-abhängige nmda-rezeptorantagonisten |
DE10153345A1 (de) * | 2001-10-29 | 2003-05-08 | Gruenenthal Gmbh | Substituierte 1H-Chinoxalin-2-on-Verbindungen und substituierte 4-Aryl- und 4-Heteroarylcyclohexan-Verbindungen |
US20070004805A1 (en) * | 2005-07-01 | 2007-01-04 | Navinta Llc | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
EP2170334B1 (de) * | 2007-06-29 | 2021-03-17 | Emory University | Nmda-rezeptor-antagonisten zur neuroprotektion |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4032766A1 (de) | 1990-10-16 | 1992-04-30 | Basf Ag | Phenylpiperidinoylamine und diese enthaltende arzneimittel |
DE4117904A1 (de) | 1991-05-31 | 1992-12-03 | Basf Ag | Substituierte n-phenylpiperidine |
EP0503411B1 (de) | 1991-03-14 | 1995-11-29 | BASF Aktiengesellschaft | Substituierte N-Phenylpiperidine und Arzneimittel daraus |
AU715216B2 (en) * | 1995-10-26 | 2000-01-20 | Mitsubishi-Tokyo Pharmaceuticals, Inc. | Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same |
-
1999
- 1999-08-09 DE DE69931316T patent/DE69931316D1/de not_active Expired - Lifetime
- 1999-08-09 US US09/370,602 patent/US6184236B1/en not_active Expired - Fee Related
- 1999-08-09 AT AT99115114T patent/ATE326219T1/de not_active IP Right Cessation
- 1999-08-13 PE PE1999000826A patent/PE20000955A1/es not_active Application Discontinuation
- 1999-08-13 NZ NZ337243A patent/NZ337243A/xx unknown
- 1999-08-13 IL IL13139999A patent/IL131399A0/xx unknown
- 1999-08-13 CA CA002280455A patent/CA2280455A1/en not_active Abandoned
- 1999-08-13 AR ARP990104079A patent/AR021770A1/es not_active Application Discontinuation
- 1999-08-16 SG SG9903973A patent/SG82014A1/en unknown
- 1999-08-16 MY MYPI99003508A patent/MY133133A/en unknown
- 1999-08-16 JP JP22965899A patent/JP3455142B2/ja not_active Expired - Fee Related
- 1999-08-16 ZA ZA9905212A patent/ZA995212B/xx unknown
- 1999-08-16 HU HU9902737A patent/HUP9902737A3/hu unknown
- 1999-08-16 YU YU38699A patent/YU38699A/sh unknown
- 1999-08-16 ID IDP990791A patent/ID23107A/id unknown
- 1999-08-17 MA MA25736A patent/MA26677A1/fr unknown
- 1999-08-17 PL PL99334949A patent/PL334949A1/xx not_active Application Discontinuation
- 1999-08-17 NO NO993948A patent/NO993948L/no unknown
- 1999-08-17 CN CNB991179110A patent/CN1141936C/zh not_active Expired - Fee Related
- 1999-08-17 KR KR1019990033814A patent/KR100341194B1/ko not_active IP Right Cessation
- 1999-08-17 BR BR9903779-3A patent/BR9903779A/pt not_active IP Right Cessation
- 1999-08-17 AU AU44537/99A patent/AU756408B2/en not_active Ceased
- 1999-08-18 TR TR1999/02015A patent/TR199902015A2/xx unknown
- 1999-08-18 HR HR98115484.2A patent/HRP990256A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TR199902015A3 (tr) | 2000-03-21 |
KR100341194B1 (ko) | 2002-06-20 |
HU9902737D0 (en) | 1999-10-28 |
JP2000109429A (ja) | 2000-04-18 |
MA26677A1 (fr) | 2004-12-20 |
ID23107A (id) | 2000-02-24 |
AR021770A1 (es) | 2002-08-07 |
NZ337243A (en) | 2000-12-22 |
HUP9902737A2 (hu) | 2000-06-28 |
NO993948D0 (no) | 1999-08-17 |
NO993948L (no) | 2000-02-21 |
CA2280455A1 (en) | 2000-02-18 |
PE20000955A1 (es) | 2000-09-28 |
AU756408B2 (en) | 2003-01-09 |
YU38699A (sh) | 2002-03-18 |
HRP990256A2 (en) | 2000-04-30 |
CN1141936C (zh) | 2004-03-17 |
MY133133A (en) | 2007-10-31 |
CN1248439A (zh) | 2000-03-29 |
IL131399A0 (en) | 2001-01-28 |
BR9903779A (pt) | 2000-09-19 |
DE69931316D1 (de) | 2006-06-22 |
TR199902015A2 (xx) | 2000-03-21 |
HUP9902737A3 (en) | 2001-01-29 |
SG82014A1 (en) | 2001-07-24 |
US6184236B1 (en) | 2001-02-06 |
ZA995212B (en) | 2000-02-18 |
PL334949A1 (en) | 2000-02-28 |
AU4453799A (en) | 2000-05-04 |
JP3455142B2 (ja) | 2003-10-14 |
KR20000017343A (ko) | 2000-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69811530T2 (de) | Verfahren zur herstellung von derivaten der taxoid-klasse | |
DE69814862D1 (de) | Verfahren zur herstellung von pyridinderivaten | |
DE69900794T2 (de) | Herstellung von halbsandwich substituierten katalysator-vorläufern | |
DE69916725D1 (de) | Vorrichtung zur herstellung von zement | |
DE69918781D1 (de) | Die verwendung von tee-polyphenolen zur herstellung von anti-chlamydia mitteln | |
DE69813869D1 (de) | Verfahren zur herstellung von thiazolidindion-derivaten | |
DE69905313D1 (de) | Verfahren zur Herstellung von 4-substituierten Azetidinon-Derivaten | |
DE69909821D1 (de) | Verfahren zur herstellung von weichem seidenpapier | |
ATE359285T1 (de) | Verwendung von scopinester derivaten zur herstellung von arzneimitteln | |
ATE326219T1 (de) | Verwendung von aryl-cyclohexylamine derivaten zur herstellung von nmda-rezeptorblockern | |
ATE293608T1 (de) | Verfahren zur herstellung von substituierten pyrimidinen | |
DE59811806D1 (de) | Verwendung von ausgewählten phytostenolestern zur herstellung von hypocholesterinämischen mitteln | |
DE69943388D1 (de) | Verfahren zur herstellung von tonern | |
DE69808068D1 (de) | Verfahren zur herstellung von indolderivaten | |
DE69727674D1 (de) | Zur herstellung von gebrannten mustern | |
DE69902120D1 (de) | Verfahren zur Herstellung von Acetylenderivaten | |
DE69928784D1 (de) | Verfahren zur herstellung von oxazolidin-2-on-derivaten | |
ATE235331T1 (de) | Verfahren zur herstellung von keramikformen | |
ATE314070T1 (de) | Verwendung von pyridoindolonderivaten zur herstellung von antikrebsmitteln | |
NO20011480D0 (no) | FremgangsmÕte for fremstilling av (-)<alfa>- | |
ATA45299A (de) | Verfahren zur herstellung von oxcarbazepin | |
DE69806357D1 (de) | Verfahren zur Herstellung fotowirksamer Coumarinderivate | |
DE60011427D1 (de) | Verfahren zur herstellung von 2-pyridylpiperidin-derivaten | |
DE59914948D1 (de) | Verwendung von 1-(aminoalkyl)-3-chinoxalin-2-on-derivaten zur herstellung von als antioxidantien wirkenden zusammensetzungen | |
DE69900543D1 (de) | Verfahren zur herstellung von 2-aminothiazolcarboxamidderivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |